000 | 01862 a2200493 4500 | ||
---|---|---|---|
005 | 20250514080640.0 | ||
264 | 0 | _c20040203 | |
008 | 200402s 0 0 eng d | ||
022 | _a0021-9258 | ||
024 | 7 |
_a10.1074/jbc.M303364200 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNair, Venugopalan D | |
245 | 0 | 0 |
_aAgonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor. _h[electronic resource] |
260 |
_bThe Journal of biological chemistry _cNov 2003 |
||
300 |
_a47053-61 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBromocriptine _xpharmacology |
650 | 0 | 4 | _aCSK Tyrosine-Protein Kinase |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aDopamine Agonists _xpharmacology |
650 | 0 | 4 | _aEnzyme Activation |
650 | 0 | 4 |
_aErbB Receptors _xbiosynthesis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 | _aPC12 Cells |
650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aProtein Binding _xdrug effects |
650 | 0 | 4 | _aProtein Serine-Threonine Kinases |
650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xbiosynthesis |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xmetabolism |
650 | 0 | 4 | _aProto-Oncogene Proteins c-akt |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aReceptor Cross-Talk |
650 | 0 | 4 |
_aReceptors, Dopamine D2 _xagonists |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 | _aTranscriptional Activation |
650 | 0 | 4 | _aTransfection |
650 | 0 | 4 | _asrc-Family Kinases |
700 | 1 | _aSealfon, Stuart C | |
773 | 0 |
_tThe Journal of biological chemistry _gvol. 278 _gno. 47 _gp. 47053-61 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.M303364200 _zAvailable from publisher's website |
999 |
_c12737715 _d12737715 |